Pricing & Reimbursement in Asia Pacific details the reimbursement situation in all major markets in the region. It is designed as a comprehensive guide to what pharmaceutical companies needs to know to ensure that its products are reimbursed by the appropriate government agency or health insurer.

Each country chapter details who is responsible for reimbursement, the processes for assessing a drug's suitability for reimbursement in that country, recent changes, government policy on healthcare costs and expected changes in the near future.

This new report will provide you with:
- An overview of the reimbursement procedures in Asia Pacific
- Information on payment bodies
- An outline of the recent changes to reimbursement regulation
- Government policy
- Generic substitution
- Predictions of future reforms to enable you to develop future strategy